Nav: Home

Fooling the test: Antibiotic-resistant bacteria that look susceptible

May 09, 2016

A diagnostic test used by hospitals says a recently isolated strain of bacteria is susceptible to the last resort antibiotic colistin. But the strain actually ignores treatment with colistin, causing lethal infections in animals.

Through "heteroresistance," a genetically identical subpopulation of antibiotic-resistant bacteria can lurk within a crowd of antibiotic-susceptible bacteria. The phenomenon could be causing unexplained treatment failures in the clinic and highlights the need for more sensitive diagnostic tests, researchers say.

In Nature Microbiology, scientists led by David Weiss, PhD, describe colistin-heteroresistant strains of Enterobacter cloacae, a type of bacteria that has been causing an increasing number of infections in hospitals around the world.

"Heteroresistance has been observed previously and its clinical relevance debated," Weiss says. "We were able to show that it makes a difference in an animal model of infection, and is likely to contribute to antibiotic treatment failures in humans."

Weiss is director of the Emory Antibiotic Resistance Center and associate professor of medicine (infectious diseases) at Emory University School of Medicine and Emory Vaccine Center. His laboratory is based at Yerkes National Primate Research Center. The co-first authors of the paper are graduate students Victor Band and Emily Crispell.

The colistin-heteroresistant bacteria were isolated from blood or urine samples from patients at Atlanta hospitals. One strain called R/S was discovered through a collaboration with Eileen Burd, PhD, director of clinical microbiology at Emory University Hospital. A separate strain called R/S-lo was identified by Sarah Satola, PhD and Monica Farley, MD at the Georgia Emerging Infections Program.

In R/S, the colistin-resistant subpopulation made up about 5 percent of the total. This subpopulation could be detected with a standard clinical test for antibiotic resistance (Etest®). R/S was also resistant to several other antibiotics.

In R/S-lo, the resistant subpopulation was only about 1 in every 10,000 bacteria, which could not be detected with Etest. Despite the tiny starting fraction of resistant bacteria, R/S-lo can withstand colistin treatment and cause a lethal infection in mice.

"We are working on more sensitive diagnostic techniques, which would be required to catch strains like this in the clinic," Weiss says.

Infectious disease experts were concerned about a November 2015 report from China of colistin resistance in another type of bacteria (E. coli), because in that case, resistance was carried on a mobile piece of DNA, known as a plasmid, which can spread to other bacteria.

Here, the resistant and susceptible subpopulations of R/S are genetically identical, the researchers report. However, the resistant subpopulation has a different pattern of gene activity, and the researchers were able to show that the bacterial gene PhoQ was critical for colistin resistance.

"We haven't tested this yet, but it suggests an add-on PhoQ inhibitor could re-sensitize some bacteria to colistin, or perhaps a less toxic relative of colistin, which other researchers are working on," Weiss says.

Colistin is viewed as a "last resort" measure for bacterial infections that are resistant to other drugs, partly because it is poisonous to the kidneys. It works by disrupting bacterial cell membranes. In the R/S strain, resistance appears to involve the bacteria modifying the lipid components of their membranes, but the precise mechanism is not clear, he says.

Experiments with mice suggest that the infected host's immune system stimulates the program of colistin resistance in the R/S bacteria. The resistant subpopulation keeps growing during colistin treatment, distinguishing heteroresistance from a related phenomenon called persistence, in which some bacteria avoid antibiotic toxicity by becoming dormant.
The research was supported by the Burroughs Wellcome Fund, the Department of Veterans Affairs (BX0027880), the National Institute of Allergy and Infectious Diseases (AI098800) and the Georgia Emerging Infections Program.

Emory Health Sciences

Related Bacteria Articles:

Conducting shell for bacteria
Under anaerobic conditions, certain bacteria can produce electricity. This behavior can be exploited in microbial fuel cells, with a special focus on wastewater treatment schemes.
Controlling bacteria's necessary evil
Until now, scientists have only had a murky understanding of how these relationships arise.
Bacteria take a deadly risk to survive
Bacteria need mutations -- changes in their DNA code -- to survive under difficult circumstances.
How bacteria hunt other bacteria
A bacterial species that hunts other bacteria has attracted interest as a potential antibiotic, but exactly how this predator tracks down its prey has not been clear.
Chlamydia: How bacteria take over control
To survive in human cells, chlamydiae have a lot of tricks in store.
More Bacteria News and Bacteria Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Do animals grieve? Do they have language or consciousness? For a long time, scientists resisted the urge to look for human qualities in animals. This hour, TED speakers explore how that is changing. Guests include biological anthropologist Barbara King, dolphin researcher Denise Herzing, primatologist Frans de Waal, and ecologist Carl Safina.
Now Playing: Science for the People

#534 Bacteria are Coming for Your OJ
What makes breakfast, breakfast? Well, according to every movie and TV show we've ever seen, a big glass of orange juice is basically required. But our morning grapefruit might be in danger. Why? Citrus greening, a bacteria carried by a bug, has infected 90% of the citrus groves in Florida. It's coming for your OJ. We'll talk with University of Maryland plant virologist Anne Simon about ways to stop the citrus killer, and with science writer and journalist Maryn McKenna about why throwing antibiotics at the problem is probably not the solution. Related links: A Review of the Citrus Greening...